Unibios Holdings S.A Capital Reinvestment Ratio

Latest as of June 2023: 0.01x

Unibios Holdings S.A capital reinvestment ratio. Unibios Holdings S.A (BIOSK) has a Capital Reinvestment Ratio of 0.01x as of June 2023, meaning it reinvests 0% of its operating cash flow (€372.03K) in capital expenditures (€2.27K). See Unibios Holdings S.A free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.

Capital Reinvestment Ratio

0.01x
Capex / Operating Cash Flow

Operating Cash Flow

€372.03K
EUR

Capital Expenditures

€2.27K
EUR

Data as of

Jun 2023
Most recent filing

Capital Reinvestment Ratio of Unibios Holdings S.A (2014–2025)

Capital reinvestment ratio of Unibios Holdings S.A from 2014 to 2025. This chart tracks Unibios Holdings S.A's Capital Reinvestment Ratio across 7 annual periods. See Unibios Holdings S.A (BIOSK) financial flexibility to measure the company's free cash flow as a share of total liabilities.

Unibios Holdings S.A Capital Reinvestment Ratio by Year (2014–2025)

Unibios Holdings S.A capital reinvestment ratio by year from 2014 to 2025. For the full cash flow conversion analysis, see BIOSK cash flow metrics.

Year Reinvestment Ratio Operating CF (EUR) Capital Expenditures YoY Change
2025 3.94x €546.05K €2.15 Million ▼ -32.8%
2024 5.86x €149.43K €874.96K ▲ +2183.7%
2023 0.26x €869.22K €222.86K ▲ +454.8%
2021 0.05x €1.06 Million €48.98K ▼ -99.8%
2017 21.21x €51.58K €1.09 Million ▲ +19880.2%
2015 0.11x €292.00K €31.00K ▲ +33.5%
2014 0.08x €264.00K €21.00K —
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow